
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/O-PCE: Difference between revisions
Jump to navigation
Jump to search
>Unity Expanded |
>Standard Fix copy-paste error for afterglow duration |
||
(44 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
{{SubstanceBox | {{SubstanceBox | ||
Line 12: | Line 11: | ||
|ModuleStructure=true | |ModuleStructure=true | ||
|ModuleNomenclature=true | |ModuleNomenclature=true | ||
|ModuleClassMembership=true | |||
|ModuleROA=true | |ModuleROA=true | ||
Line 33: | Line 33: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption=Molecular structure of O-PCE | ||
|SkeletalImageFile=File: | |SkeletalImageFile=File:O-PCE.svg | ||
|SkeletalImageWidth=245px | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
Line 40: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=O-PCE, Eticyclidone | |NameCommon=[[common name::O-PCE]], [[common name::Eticyclidone]] | ||
|NameSubstitution=2'-Oxo-PCE | |NameSubstitution=2'-Oxo-PCE | ||
|NameSystematic=2-( | |NameSystematic=2-(Ethylamino)-2-phenylcyclohexan-1-one | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[psychoactive class::Dissociative]] | |||
|EffectClass=[[Dissociative]] | |ChemicalClass=[[chemical class::Arylcyclohexylamine]] | ||
|ChemicalClass=[[Arylcyclohexylamine]] | |||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
|OralROA=true | |OralROA=true | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::1]] | |OralROA_Threshold=[[Oral threshold dose::1]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::3]] - [[Oral max light dose:: | |OralROA_Light=[[Oral min light dose::3]] - [[Oral max light dose::5]] mg | ||
|OralROA_Common=[[Oral min common dose:: | |OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong=[[Oral min strong dose:: | |OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | ||
|OralROA_Heavy=[[Oral | |OralROA_Heavy=[[Oral heavy dose::25]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min | |OralROA_Duration=[[Oral min total time::3]] - [[Oral max total time::6]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time:: | |OralROA_Onset=[[Oral min onset time::20]] - [[Oral max onset time::40]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak= | |OralROA_Peak= | ||
|OralROA_Offset= | |OralROA_Offset= | ||
|OralROA_Aftereffects=[[Oral min afterglow time:: | |OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | ||
|InsufflatedROA=true | |InsufflatedROA=true | ||
Line 72: | Line 70: | ||
|InsufflatedROA_Caption= | |InsufflatedROA_Caption= | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
|InsufflatedROA_Threshold=[[Insufflated threshold dose:: | |InsufflatedROA_Threshold=[[Insufflated threshold dose::2]] [[Insufflated dose units::mg]] | ||
|InsufflatedROA_Light=[[Insufflated min light dose::3]] - [[Insufflated max light dose::6]] mg | |InsufflatedROA_Light=[[Insufflated min light dose::3]] - [[Insufflated max light dose::6]] mg | ||
|InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | |InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | ||
|InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | |InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | ||
|InsufflatedROA_Heavy=[[Insufflated | |InsufflatedROA_Heavy=[[Insufflated heavy dose::20]] mg + | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= | ||
|InsufflatedROA_Duration=[[Insufflated min | |InsufflatedROA_Duration=[[Insufflated min total time::3]] - [[Insufflated max total time::5]] [[Insufflated total time units::hours]] | ||
|InsufflatedROA_Onset=[[Insufflated min onset time:: | |InsufflatedROA_Onset=[[Insufflated min onset time::2]] - [[Insufflated max onset time::5]] [[Insufflated onset time units::minutes]] | ||
|InsufflatedROA_Peak= | |InsufflatedROA_Peak= | ||
|InsufflatedROA_Offset= | |InsufflatedROA_Offset= | ||
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max | |InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max afterglow time::12]] [[Insufflated afterglow time units::hours]] | ||
}} | }} |
Latest revision as of 13:45, 4 June 2022
SubstanceBox/O-PCE | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||
Common names | O-PCE, Eticyclidone | ||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 2'-Oxo-PCE | ||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 2-(Ethylamino)-2-phenylcyclohexan-1-one | ||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||
|